Roche's rheumatoid arthritis drug Actemra failed to help patients with early-stage COVID-19 pneumonia in an Italian study, researchers reported on Wednesday, but the Swiss drugmaker is testing the medicine in another trial against the illness caused by the new coronavirus.
FILE PHOTO: The peak of Mount Pilatus is seen in the background as workers clean the windows of a building of Roche in Rotkreuz May 27, 2020. REUTERS/Arnd Wiegmann/File Photo
In the study, Actemra did not reduce severe respiratory symptoms, intensive care visits, or death any better than standard treatments. “Although not effective in all patients with COVID-19 pneumonia, it is possible that selected subgroups of patients may have a better response to the drug,” the study’s administrators said in a statement.
Meanwhile, Roche has completed enrollment of its own Actemra study in patients hospitalized with severe pneumonia caused by COVID-19.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Dexamethasone Improves Survival in Severe Covid-19 Patients, Study FindsA generic steroid drug is the first to show in a clinical trial it could improve the survival of severely ill coronavirus patients, University of Oxford researchers said
Lire la suite »
Transmission of COVID-19 to Baby During Birth Is Uncommon, Study SaysRead about a new systematic review of 49 studies from the University of Nottingham that found transmission from mom to baby during birth and breastfeeding is relatively uncommon.
Lire la suite »
Coronavirus: Dexamethasone can improve COVID-19 survival, study saysResearchers in England say they have the first evidence that a drug can improve chances of survival from COVID-19.
Lire la suite »
Study showing teens less likely to catch Covid-19 may mean school can reopen, expert saysA study showing that children and teens are half as likely as adults to become infected with coronavirus might be good news for schools seeking to reopen, a former top health policy adviser to former President Obama said
Lire la suite »
WHO moves to update COVID-19 guidance after 'great news' in drug studyThe World Health Organization (WHO) said it was moving to update its guidelines on treating people stricken with COVID-19 to reflect results of a clinical trial that showed a cheap, common steroid can help save critically ill patients.
Lire la suite »